267 related articles for article (PubMed ID: 9110194)
1. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.
Bax JJ; Visser FC; van Lingen A; Cornel JH; Fioretti PM; van der Wall EE
Int J Card Imaging; 1997 Apr; 13(2):145-55; discussion 157-60. PubMed ID: 9110194
[TBL] [Abstract][Full Text] [Related]
2. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
[TBL] [Abstract][Full Text] [Related]
3. Myocardial F-18 fluorodeoxyglucose imaging by SPECT.
Bax JJ; Visser FC; van Lingen A; Visser CA; Teule GJ
Clin Nucl Med; 1995 Jun; 20(6):486-90. PubMed ID: 7648727
[TBL] [Abstract][Full Text] [Related]
4. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
[TBL] [Abstract][Full Text] [Related]
5. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
6. F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization.
Bax JJ; Cornel JH; Visser FC; Fioretti PM; Huitink JM; van Lingen A; Sloof GW; Visser CA
J Nucl Cardiol; 1997; 4(4):302-8. PubMed ID: 9278877
[TBL] [Abstract][Full Text] [Related]
7. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
[TBL] [Abstract][Full Text] [Related]
8. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
[TBL] [Abstract][Full Text] [Related]
9. Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: relationship to coronary anatomy and ventricular function.
Fragasso G; Chierchia SL; Rossetti E; Sciammarella MG; Conversano A; Lucignani G; Landoni C; Calori G; Margonato A; Fazio F
Nucl Med Commun; 1997 Mar; 18(3):191-9. PubMed ID: 9106772
[TBL] [Abstract][Full Text] [Related]
10. Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: an alternative for determining myocardial viability.
Sandler MP; Patton JA
J Nucl Cardiol; 1996; 3(4):342-9. PubMed ID: 8799254
[TBL] [Abstract][Full Text] [Related]
11. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
[TBL] [Abstract][Full Text] [Related]
12. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
[TBL] [Abstract][Full Text] [Related]
13. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography.
de Silva R; Yamamoto Y; Rhodes CG; Iida H; Nihoyannopoulos P; Davies GJ; Lammertsma AA; Jones T; Maseri A
Circulation; 1992 Dec; 86(6):1738-42. PubMed ID: 1451245
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects.
Brunken RC; Mody FV; Hawkins RA; Nienaber C; Phelps ME; Schelbert HR
Circulation; 1992 Nov; 86(5):1357-69. PubMed ID: 1423947
[TBL] [Abstract][Full Text] [Related]
15. [Indications for clinical applications of positron emission tomography in cardiology. Position report of the PET Cardiology Study Group of the German Society of Nuclear Medicine and the Nuclear Cardiology Study Circle of the German Society of Cardiology].
Z Kardiol; 1996 Jul; 85(7):453-68. PubMed ID: 8928543
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
[TBL] [Abstract][Full Text] [Related]
17. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
Lucignani G; Paolini G; Landoni C; Zuccari M; Paganelli G; Galli L; Di Credico G; Vanoli G; Rossetti C; Mariani MA
Eur J Nucl Med; 1992; 19(10):874-81. PubMed ID: 1451704
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
[TBL] [Abstract][Full Text] [Related]
19. Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?
Kalff V; Berlangieri SU; Van Every B; Rowe JL; Lambrecht RM; Tochon-Danguy HJ; Egan GF; McKay WJ; Kelly MJ
Eur J Nucl Med; 1995 Jul; 22(7):625-32. PubMed ID: 7498223
[TBL] [Abstract][Full Text] [Related]
20. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
Schröter G; Schneider-Eicke J; Schwaiger M
Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
